Oppenheimer Asset Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $756K | Buy |
22,408
+1,677
| +8% | +$56.5K | 0.01% | 796 |
|
|
2025
Q1 | $659K | Buy |
20,731
+5,462
| +36% | +$174K | 0.01% | 800 |
|
|
2024
Q4 | $593K | Sell |
15,269
-159
| -1% | -$6.18K | 0.01% | 829 |
|
|
2024
Q3 | $694K | Sell |
15,428
-1,500
| -9% | -$67.5K | 0.01% | 803 |
|
|
2024
Q2 | $707K | Buy |
16,928
+1,565
| +10% | +$65.4K | 0.01% | 781 |
|
|
2024
Q1 | $699K | Sell |
15,363
-263
| -2% | -$12K | 0.01% | 767 |
|
|
2023
Q4 | $722K | Buy |
15,626
+2,097
| +16% | +$96.9K | 0.01% | 782 |
|
|
2023
Q3 | $550K | Buy |
13,529
+1,400
| +12% | +$57K | 0.01% | 827 |
|
|
2023
Q2 | $588K | Buy |
12,129
+367
| +3% | +$17.8K | 0.01% | 822 |
|
|
2023
Q1 | $580K | Buy |
11,762
+608
| +5% | +$30K | 0.01% | 815 |
|
|
2022
Q4 | $564K | Sell |
11,154
-491
| -4% | -$24.8K | 0.01% | 820 |
|
|
2022
Q3 | $585K | Buy |
11,645
+48
| +0.4% | +$2.41K | 0.01% | 794 |
|
|
2022
Q2 | $567K | Buy |
11,597
+378
| +3% | +$18.5K | 0.01% | 825 |
|
|
2022
Q1 | $674K | Buy |
11,219
+2,402
| +27% | +$144K | 0.01% | 849 |
|
|
2021
Q4 | $700K | Buy |
8,817
+1,628
| +23% | +$129K | 0.01% | 879 |
|
|
2021
Q3 | $637K | Buy |
7,189
+1,486
| +26% | +$132K | 0.01% | 870 |
|
|
2021
Q2 | $568K | Buy |
5,703
+1,198
| +27% | +$119K | 0.01% | 914 |
|
|
2021
Q1 | $405K | Buy |
+4,505
| New | +$405K | 0.01% | 969 |
|